OTTAWA, Aug. 18, 2018 /CNW/ - Health Canada is advising Canadians that, as a precautionary measure, Teva Canada is expanding its voluntary recall to include eight additional lots of valsartan products ...

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/12.5 mg, 90-count bottles, lot. Nos. 20x006 and 21x006, expiration 11/2018. Amlodipine, Valsartan, and Hydrochlorothiazide Tablets ...

Earlier this month, the FDA announced a voluntary recall of some valsartan-containing drugs after N-nitrosodimethylamine (NDMA) was found in the active pharmaceutical ingredients (API) manufactured by ...

A new posthoc analysis of data from the Valsartan Heart Failure Trial (Val-HeFT) has confirmed that atrial fibrillation (AF) is independently associated with an increased risk of all-cause mortality ...

Sacubitril, valsartan; 6mg/6mg, 15mg/16mg; oral pellets in caps. Entresto Sprinkle is supplied as film-coated oral pellets are round, biconvex in shape, and provided in a hard capsule in the following ...

Although the patent on valsartan (Diovan, Novartis) expired last Friday, a generic version of the popular antihypertensive drug has yet to make it to market. By contrast, a generic version of Diovan ...

Please provide your email address to receive an email when new articles are posted on . “In many individuals, [hypertrophic cardiomyopathy] is oftentimes genetic, caused by pathogenic variants in ...

Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone after stabilization for worsening heart failure in patients with an ejection fraction (EF) above ...

The list of valsartan products that are NOT recalled has been updated to: provide corrected information for Diovan products; add an additional Mylan-Valsartan product; and to add Entresto products. No ...

Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone after stabilization for worsening heart failure in patients with an ejection fraction (EF) above ...